1. Home
  2. PRAX vs IBCP Comparison

PRAX vs IBCP Comparison

Compare PRAX & IBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRAX
  • IBCP
  • Stock Information
  • Founded
  • PRAX 2015
  • IBCP 1864
  • Country
  • PRAX United States
  • IBCP United States
  • Employees
  • PRAX N/A
  • IBCP N/A
  • Industry
  • PRAX Biotechnology: Pharmaceutical Preparations
  • IBCP Major Banks
  • Sector
  • PRAX Health Care
  • IBCP Finance
  • Exchange
  • PRAX Nasdaq
  • IBCP Nasdaq
  • Market Cap
  • PRAX 599.7M
  • IBCP 646.9M
  • IPO Year
  • PRAX 2020
  • IBCP N/A
  • Fundamental
  • Price
  • PRAX $46.32
  • IBCP $33.75
  • Analyst Decision
  • PRAX Strong Buy
  • IBCP Hold
  • Analyst Count
  • PRAX 11
  • IBCP 3
  • Target Price
  • PRAX $114.73
  • IBCP $36.67
  • AVG Volume (30 Days)
  • PRAX 299.7K
  • IBCP 68.5K
  • Earning Date
  • PRAX 08-12-2025
  • IBCP 07-24-2025
  • Dividend Yield
  • PRAX N/A
  • IBCP 3.10%
  • EPS Growth
  • PRAX N/A
  • IBCP 6.78
  • EPS
  • PRAX N/A
  • IBCP 3.14
  • Revenue
  • PRAX $8,122,000.00
  • IBCP $219,516,000.00
  • Revenue This Year
  • PRAX N/A
  • IBCP N/A
  • Revenue Next Year
  • PRAX $6,358.50
  • IBCP $6.04
  • P/E Ratio
  • PRAX N/A
  • IBCP $10.70
  • Revenue Growth
  • PRAX 270.02
  • IBCP 6.57
  • 52 Week Low
  • PRAX $26.70
  • IBCP $25.46
  • 52 Week High
  • PRAX $91.83
  • IBCP $40.32
  • Technical
  • Relative Strength Index (RSI)
  • PRAX 63.87
  • IBCP 69.54
  • Support Level
  • PRAX $40.93
  • IBCP $32.11
  • Resistance Level
  • PRAX $44.40
  • IBCP $31.97
  • Average True Range (ATR)
  • PRAX 2.26
  • IBCP 0.75
  • MACD
  • PRAX -0.08
  • IBCP 0.31
  • Stochastic Oscillator
  • PRAX 95.12
  • IBCP 93.40

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

About IBCP Independent Bank Corporation

Independent Bank Corp (Ionia MI) operates as a commercial bank. It offers a broad range of banking services to individuals and businesses, including checking and savings accounts, commercial lending, direct and indirect consumer financing, mortgage lending, and safe deposit box services. It also provides internet and mobile banking capabilities to its customers.

Share on Social Networks: